Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-02-06T17:02:10.255Z Has data issue: false hasContentIssue false

Rare case of Kawasaki disease with cardiac tamponade and giant coronary artery aneurysms

Published online by Cambridge University Press:  11 February 2021

Andrea Vergara*
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy Department of Cardiology, Division of Clinical Cardiology, A.O.R.N. “Sant’Anna e San Sebastiano”, Caserta, Italy
Emanuele Monda
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
Cinzia Mautone
Affiliation:
Division of Pediatrics, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy
Francesca Renon
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
Antonio Di Masi
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
Mario Giordano
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy Department of Cardiology, Division of Pediatric Cardiology, A.O.R.N. dei Colli, Monaldi Hospital, Naples, Italy
Giuseppe Limongelli
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart Department of Cardiovascular Sciences, University College of London and St. Bartholomew’s Hospital, London, UK
Paolo Calabrò
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy Department of Cardiology, Division of Clinical Cardiology, A.O.R.N. “Sant’Anna e San Sebastiano”, Caserta, Italy
Giovanbattista Capozzi
Affiliation:
Department of Cardiology, Division of Pediatric Cardiology, A.O.R.N. dei Colli, Monaldi Hospital, Naples, Italy
Maria G. Russo
Affiliation:
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy Department of Cardiology, Division of Pediatric Cardiology, A.O.R.N. dei Colli, Monaldi Hospital, Naples, Italy
*
Author for correspondence: Dr A. Vergara, MD, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, 80131, Italy. Tel: +393339358442; Fax: +390817062815. E-mail: andreavergara2712@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Kawasaki disease is an acute systemic vascular disease, generally self-limited and typically affecting children <5 years old, which leads to coronary artery aneurysms in about 25% of untreated cases. Cardiovascular involvement is characterised by transient pancarditis, in acute phase, while coronary illness, ranging from mild dilation to giant CAAs occurs late, rarely before the 10th day since fever onset. Here, we describe a peculiar case of KD, which occurred in a 4-month-old infant and presented with exudate cardiac tamponade and early giant aneurism of both the proximal right coronary artery) and the left circumflex coronary artery, in acute phase of the disease.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Case report

A 4-month-old infant was presented with high fever (>39°C, refractory to therapy, started 4 days before) and severe respiratory distress. During physical examination, he showed conjunctival injection, oral, and pharyngeal erythema, cervical lymphadenopathy, maculopapular rash, muffled heart sounds, and hypotension. Chest X-ray demonstrated marked enlargement of the cardiac outline and echocardiography showed a large pericardial effusion with cardiac tamponade. Thus, he was transferred to Pediatric Cardiac Surgery to undergo pericardiocentesis, and the pericardial fluid was citrine yellow, exudative, of inflammatory nature. At the post–procedure, ultrasound evaluation dilation of the proximal right coronary artery with a giant aneurysm at the origin (11 mm, z score +33.18) and giant aneurysm of the left circumflex coronary artery (4 mm, z score +12.50) were identified; therefore, diagnosis of KD was made and to reduce inflammation, immunoglobulin therapy (2 g/kg in 12 hours) and acetylsalicylic acid (40 mg/kg/daily) therapy was started, as well as anticoagulant therapy with Dicumarol (to obtain INR target levels 2–3).

Four months after the disease onset, the patient underwent a coronarography that confirmed the giant RCA aneurysm (Fig 1) in absence of downstream flow, and the giant LCX aneurism, partially filled by a collateral circulation. The patient underwent a regular cardiological follow-up and serial echocardiographic evaluations that documented a progressive size reduction of the coronary artery aneurysm. Three years later, a second coronarography was performed that confirmed the normal calibre of both the RCA and the LCX, and the absence of the aneurysmal formations previously reported. It was decided to suspend anticoagulant therapy and to continue with ASA at an antiaggregant dosage (3–5 mg/kg/daily).

Figure 1. Coronarography scan shows the presence of a giant aneurysm and low flow in the distal tract of the right coronary artery.

Discussion

The onset of KD is generally characterised by acute and intense febrile symptoms, frequently associated with a general cardiac involvement (pancarditis), and is characterised, in the beginning, by symptoms of mild intensity. Although KD is generally self-limiting, 20–25% of patients develop severe complications, such as CAA (z score ≥10, or absolute dimension ≥8 mm), Reference McCrindle, Rowley and Newburger1Reference Liu, Lin, Wang and Wu2 myocardial infarction, and heart failure. Reference Dahlem, von Rosentiel, Lam and Kuijpers3

Coronary artery involvement is a frequent complication of KD, and a giant aneurysm can occur, in particular in untreated patients during the subacute phase. Reference McCrindle, Rowley and Newburger1 After the introduction of IVIG and high-dosage ASA for the treatment of KD, the occurrence and the regression of the CAA was improved. Recently, Kevin et al described the natural history of CAA in the United States of America KD patients and identified factors associated with CAA regression. Reference Friedman, Gauvreau and Hamaoka-Okamoto4 In their large cohort, CAA regression occurred in 75% of patients. However, they found that lack of CAA regression was associated with larger CAA z score at diagnosis (in particular >10 z score), and bilateral CAA. Pericardial effusion represents another common complication of KD, reported in 6–24% of patients Reference Chantepie, Mauran, Lusson, Vaillant and Bozio5 ; however, the cardiac tamponade is an exceptional event, which occurs principally in the convalescent phase of the disease, mostly due to an aneurysmal rupture. Reference Kuppuswamy, Gukop, Sutherland and Venkatachalam6Reference Imai, Sunagawa and Ayusawa7

In our case, both the CAA formation and the cardiac tamponade, which was not related to CAA rupture, occurred in acute phase of KD. We believe that the early onset of this complication can be related to the young age of the patient. Indeed, in infants younger than 6 months of age, KD seems to have a rapidly fatal course in acute phase of disease, principally related to CAA complication, such as thrombosis and rupture that can lead to cardiac tamponade, myocardial infarction, and sudden cardiac death Reference Maresi, Passantino and Midulla8 ; it was supposed that the susceptibility to coronary complication can be associated to the small thickness of the coronary walls in this age, which may favour the inflammation of the three arterial tunics (i.e., panarteritis). Reference Maresi, Passantino and Midulla8 Another important finding was the complete CAA regression, which is considered as an extraordinary event in young patients with bilateral CAA and giant aneurysm (z score >10). Reference Friedman, Gauvreau and Hamaoka-Okamoto4 This finding is consistent with previous studies showing that the incidence of CAA regression is higher in children less than 1 year of age compared to older patients. Reference Takahashi, Mason and Lewis9

Conclusion

In patients <6 months of age, the onset of KD may be extremely aggressive, and a delayed diagnosis may lead to severe complications and death. In our case, the infant developed two important life-threatening complications of KD, the cardiac tamponade and the CAA formation; however, with an appropriate management, he showed a good long-term prognosis. These findings confirmed the importance of the early diagnosis and the proper treatment of KD, particularly in infants.

Acknowledgements

None.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Conflicts of interest

None.

Ethical standards

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committees.

References

McCrindle, BW, Rowley, AH, Newburger, JW, et al. American heart association rheumatic fever, endocarditis, and kawasaki disease committee of the council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; council on cardiovascular surgery and anesthesia; and council on epidemiology and prevention. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation 2017; 135: e927e999.Google Scholar
Liu, YC, Lin, MT, Wang, JK, Wu, MH. State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association. Pediatr Neonatol 2018; 59: 543552.CrossRefGoogle ScholarPubMed
Dahlem, PG, von Rosentiel, IA, Lam, J, Kuijpers, WT. Pulse methylprednisolone therapy for impeding cardiac tamponade in immunoglobulin-resistant Kawasaki disease. Intensive Care Med 1999; 25: 11371139.10.1007/s001340051025CrossRefGoogle Scholar
Friedman, KG, Gauvreau, K, Hamaoka-Okamoto, A, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 2016; 5: e003289.10.1161/JAHA.116.003289CrossRefGoogle ScholarPubMed
Chantepie, A, Mauran, P, Lusson, JR, Vaillant, MC, Bozio, A. Cardiovascular complications of Kawasaki syndrome: results of a French multicenter study. Arch Pediatr 2001; 8: 713719.CrossRefGoogle ScholarPubMed
Kuppuswamy, M, Gukop, P, Sutherland, G, Venkatachalam, C. Kawasaki disease presenting as cardiac tamponade with ruptured giant aneurysm of the right coronary artery. Interact Cardiovasc Thorac Surg 2010; 10: 317318.10.1510/icvts.2009.215731CrossRefGoogle ScholarPubMed
Imai, Y, Sunagawa, K, Ayusawa, M, et al. A fatal case of ruptured giant coronary artery aneurysm. Eur J Pediatr 2006; 165: 130133.CrossRefGoogle ScholarPubMed
Maresi, E, Passantino, R, Midulla, R, et al. Sudden infant death caused by a ruptured coronary aneurysm during acute phase of atypical Kawasaki disease. Hum Pathol 2001; 32: 14071409.CrossRefGoogle ScholarPubMed
Takahashi, M, Mason, W, Lewis, AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 1987; 75: 387394.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Coronarography scan shows the presence of a giant aneurysm and low flow in the distal tract of the right coronary artery.